Jupiter Life Line Hospitals credit ratios

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendLast 12Mto Sep 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023
5095093260.0—
−35.3−35.3−277−318—
0.33×0.33×0.24×0.00×—
−0.02×−0.02×−0.20×−0.27×—
1.48×1.48×1.10×0.00×—
−0.10×−0.10×−0.93×−1.34×—
7.83×7.83×22.70×7.43×3.85×
23.8%24.8%19.4%0.0%—
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

JLHL₹260.10

Jupiter Life Line Hospitals Ltd.

· Pharma & Health
₹ CrorePeersAPOLLOHOSPMAXHEALTHKIMSHCGMARKSANSMETROPOLISPARKHOSPSCORONAMcap ₹1,705 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/09/2026
Total Debt—0.0325.7508.5508.5
Net Debt—-318.1-277.2-35.3-35.3
Total Debt/Equity—0.000.240.330.33
Net Debt/Equity—-0.27-0.20-0.02-0.02
Total Debt/EBITDA—0.001.101.481.48
Net Debt/EBITDA—-1.34-0.93-0.10-0.10
Interest Coverage (EBIT/Interest)3.857.4322.707.837.83
Total Debt/Total Capital %—0.0019.3724.7723.77
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.